个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Zhang, Li[1] * ; Huang, Yan[1] ; Hu, Zhihuang[1] ; Liu, Yun-Peng[2] ; Zhou, Jianying[3] ; Xu, Nong[4] ; Li, Baolan[5] ; Wu, Gang[6] ; Liu, Xiaoqing[7] ; Fang, Jian[8] ; Li, Kai[9] ; Wei, Liu[10] ; Lu, You[11] ; Wang, Meng-Zhao[12] ; Liu, Wenzhao[13] ; Liang, Houjie[14] ; Zhang, Yiping[15] ; Huang, Cheng[16] ; Wang, Shunjin[17] ; Wang, Yajie[18] ; Yu, Shiying[19] ; Chang, Jianhua[20] ; Wang, Zhehai[21] ;
单位： [1]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China [2]China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China [3]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China [4]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou, Zhejiang, Peoples R China [5]Capital Med Hosp, Beijing Chest Hosp, Dept Gen Med, Beijing, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Tumor Ctr, Wuhan, Hubei, Peoples R China [7]Acad Mil Med Sci, Affiliated Hosp, Dept Thorac Med Oncol, Beijing, Peoples R China [8]Beijing Canc Hosp & Inst, Dept Thorac Med Oncol, Beijing, Peoples R China [9]Tianjin Med Univ Canc Inst & Hosp, Dept Thorac Med Oncol, Tianjin, Peoples R China [10]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [11]Sichuan Univ, West China Sch Med, West China Hosp, Dept Thorac Oncol, Chengdu, Sichuan, Peoples R China [12]Beijing Union Med Coll Hosp, Dept Resp Dis, Beijing, Peoples R China [13]Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian, Peoples R China [14]Third Mil Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China [15]Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China [16]Fujian Prov Canc Hosp, Dept Thorac Oncol, Fuzhou, Fujian, Peoples R China [17]Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang, Peoples R China [18]Shanghai Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China [19]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Caner Ctr, Wuhan, Hubei, Peoples R China [20]Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China [21]Shandong Canc Hosp, Dept Med Oncol, Jinan, Peoples R China
出处：
ISSN：

关键词： Lung cancer chemotherapy biomarker

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2012]版：
大类 | 2 区 医学
小类 | 2 区 呼吸系统 3 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2011]版：
Q1 RESPIRATORY SYSTEM Q2 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者：
第一作者单位： [1]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Li,Huang Yan,Hu Zhihuang,et al.BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER[J].JOURNAL OF THORACIC ONCOLOGY.2013,8:S330-S330.
APA：
Zhang, Li,Huang, Yan,Hu, Zhihuang,Liu, Yun-Peng,Zhou, Jianying...&Wang, Zhehai.(2013).BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER.JOURNAL OF THORACIC ONCOLOGY,8,
MLA：
Zhang, Li,et al."BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER".JOURNAL OF THORACIC ONCOLOGY 8.(2013):S330-S330

相关文献

[1]AKAP4 is a circulating biomarker for non-small cell lung cancer [2]Metabonomic characteristics and biomarker research of human lung cancer tissues by HR 1H NMR spectroscopy [3]Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer [4]异鼠李素抑制耐吉非替尼人肺癌细胞PC9增殖的研究术 [5]Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer [6]Identification of RFC5 as a novel potential prognostic biomarker in lung cancer through bioinformatics analysis [7]Comprehensive serum N-glycan profiling identifies a biomarker panel for early diagnosis of non-small-cell lung cancer [8]Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer [9]Nutritional status changes in patients with advanced non-small cell lung cancer receiving first-line chemotherapy [10]Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection

资源点击量：426 今日访问量：0 总访问量：408 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）